Thursday, May 9, 2013

• Vanda Pharmaceuticals Reports First Quarter 2013 ResultsPR Newswire( (Thu, May 9)

Thursday, April 18, 2013

• Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013PR Newswire( (Thu, Apr 18)

Wednesday, April 17, 2013

• Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical OfficerPR Newswire( (Wed, Apr 17)

Thursday, April 4, 2013

• Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry ConferencePR Newswire( (Thu, Apr 4)

Monday, March 25, 2013

• Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally BlindPR Newswire( (Mon, Mar 25)

Thursday, March 14, 2013

• Vanda Withdraws Its Marketing Authorization Application For Fanaptum™ In The European UnionPR Newswire( (Thu, Mar 14)

Wednesday, February 27, 2013

• Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care ConferencePR Newswire( (Wed, Feb 27)

Tuesday, February 12, 2013

• Vanda Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 ResultsPR Newswire( (Tue, Feb 12)

Thursday, January 31, 2013

• Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary EndpointPR Newswire( (Thu, Jan 31)